article · Frontiers in Molecular Biosciences
Colorectal cancer (CRC) is one of the most common cancers in the world and one of the leading causes of cancer mortality. In this study, zinc oxide nanoparticles (PlS-ZnO NPs) were synthesized eco-friendly using an aqueous extract from the stems of <i>Persicaria lapathifolia</i> and their anticancer and antibacterial activities were evaluated. The PlS-ZnO NPs were prepared by a simple sol-gel combustion method and investigated by different spectroscopic and microscopic techniques. The resulting nanoparticles were of polygonal and hexagonal morphology with the average size of 21.45 nm. The PlS-ZnO NPs exhibited high cytotoxicity against human colorectal cancer cell line (HCT-116) with IC50 value of 11.31 μg/mL. Cytomorphological studies showed that these nanoparticles killed cells through both apoptosis and necrosis. Apoptotic process was accompanied by enhancement of intracellular ROS and MMP. Moreover, the PlS-ZnO NPs exhibited excellent antibacterial activity towards different pathogenic bacteria like <i>Bacillus subtilis</i>, <i>Bacillus megaterium</i>, <i>Vibrio cholerae</i> and <i>Proteus vulgaris</i> and was found to be better than the positive control amoxicillin. These results indicate that the green synthesized PlS-ZnO NPs can be considered as a potential multifunctional agent for the treatment of colorectal cancer and bacterial infections. The environmentally friendly and cost-effective synthesis of PlS-ZnO nanoparticles (NPs) utilizing <i>P. lapathifolia</i> enhances the potential of this nanomaterial for medical applications. This sustainable approach not only reduces environmental impact but also aligns with the increasing demand for biocompatible materials in healthcare.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3389/fmolb.2025.1601811
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.